Overview
MEPAN syndrome stands for Mitochondrial Enoyl CoA Reductase Protein Associated Neurodegeneration. It is a very rare inherited brain disease that affects how nerve cells in the brain work and survive over time. The condition is caused by changes (mutations) in a gene called MECR, which helps the body make fatty acids inside the mitochondria — the tiny power plants inside every cell. When this gene does not work properly, certain parts of the brain, especially an area called the basal ganglia, begin to break down over time. This places MEPAN syndrome in a group of conditions called neurodegeneration with brain iron accumulation (NBIA). Children with MEPAN syndrome usually appear healthy at birth but begin showing symptoms in early childhood, most often between ages 3 and 10. The most common problems include difficulty with movement and coordination, involuntary muscle movements (dystonia), vision loss due to damage to the optic nerve, and in some cases, intellectual challenges. The disease tends to get worse slowly over time, though the speed varies from person to person. Right now there is no cure for MEPAN syndrome. Treatment focuses on managing symptoms, especially movement problems and vision changes. Some early research suggests that a supplement called pantothenate (vitamin B5) may help slow the disease in some patients, and this is an active area of investigation. A team of specialists is usually needed to provide the best care.
Also known as:
Key symptoms:
Dystonia — involuntary, sustained muscle contractions causing twisting or abnormal posturesProblems with coordination and balance (ataxia)Optic atrophy — damage to the optic nerve leading to vision lossDifficulty walking or changes in the way a child walksSlurred or unclear speechIntellectual disability or learning difficulties in some childrenMuscle stiffness or rigidityTremors or shakingFatigue and low energySlow progression of neurological symptoms over time
Clinical phenotype terms (31)— hover any for plain English
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Childhood
Begins in childhood, roughly ages 1 to 12
Treatments
No FDA-approved treatments are currently listed for MEPAN syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for MEPAN syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for MEPAN syndrome.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to MEPAN syndrome.
Community
No community posts yet. Be the first to share your experience with MEPAN syndrome.
Start the conversation →Latest news about MEPAN syndrome
No recent news articles for MEPAN syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.What stage is my child's disease at, and what changes should I watch for over the next year?,Should my child be tested for MECR mutations, and should other family members be tested too?,Is pantothenate supplementation something we should consider, and what does the current evidence say?,What medications are available to help manage dystonia, and what are the risks and benefits?,Are there any clinical trials or research studies that my child might be eligible for?,What therapies — physical, occupational, or speech — would you recommend, and how often should we attend?,How should we prepare an emergency plan if my child has a sudden worsening of symptoms?
Common questions about MEPAN syndrome
What is MEPAN syndrome?
MEPAN syndrome stands for Mitochondrial Enoyl CoA Reductase Protein Associated Neurodegeneration. It is a very rare inherited brain disease that affects how nerve cells in the brain work and survive over time. The condition is caused by changes (mutations) in a gene called MECR, which helps the body make fatty acids inside the mitochondria — the tiny power plants inside every cell. When this gene does not work properly, certain parts of the brain, especially an area called the basal ganglia, begin to break down over time. This places MEPAN syndrome in a group of conditions called neurodegenera
How is MEPAN syndrome inherited?
MEPAN syndrome follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does MEPAN syndrome typically begin?
Typical onset of MEPAN syndrome is childhood. Age of onset can vary across affected individuals.